Glipizide

Product NDC
21695-470
11-digit product format
216950470
Labeler code
21695
Product ID
21695-470_e253ec37-78bb-4168-b630-2b7e33607f9d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Glipizide
Dosage form
TABLET
Route
ORAL
Labeler
Rebel Distributors Corp
Application
ANDA074223
Marketing category
ANDA
Marketing start
1995-02-27
Marketing end
0000-00-00
Substance
GLIPIZIDE
Active strength
10 mg/1
Pharmacologic classes
Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
ec4adfb0-aabc-95b9-ad07-5cb8f8533a09Product name220250625
b1de1ca9-d9db-4f4b-2103-09e2014d30d5Product name520180912
2dee091b-3b8c-d27a-b1ba-fcb0d32e776aProduct name120140508

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
21695-470-00Glipizide100 in 1 BOTTLETABLET1001
21695-470-30Glipizide30 in 1 BOTTLETABLET301
21695-470-60Glipizide60 in 1 BOTTLETABLET601
21695-470-78Glipizide180 in 1 BOTTLETABLET1801
21695-470-90Glipizide90 in 1 BOTTLETABLET901

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
21695-470-00EA - Each21695-47041099df0-fcaa-4941-bdaa-c535189dbef612013-02-13
21695-470-30EA - Each21695-470b90602e2-046f-4cc6-a02d-f20e9db60ebe12012-07-24
21695-470-60EA - Each21695-470fcf31a64-b9a5-413b-a87e-28b339903db112012-07-24
21695-470-78EA - Each21695-470d1f9a242-e43e-4fe9-a5fb-dd19e6f1d0ee12012-07-24
21695-470-90EA - Each21695-470fb957eb1-557d-4cab-9884-2e1a7727603d12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
GLIPIZIDEACTIVE INGREDIENTX7WDT95N5CGLIPIZIDE TABLET [REBEL DISTRIBUTORS CORP]1
GLIPIZIDEACTIVE MOIETYX7WDT95N5CGLIPIZIDE TABLET [REBEL DISTRIBUTORS CORP]1
ANHYDROUS LACTOSEINACTIVE INGREDIENT3SY5LH9PMKGLIPIZIDE TABLET [REBEL DISTRIBUTORS CORP]1
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UGLIPIZIDE TABLET [REBEL DISTRIBUTORS CORP]1
COLLOIDAL SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4GLIPIZIDE TABLET [REBEL DISTRIBUTORS CORP]1
CROSCARMELLOSE SODIUMINACTIVE INGREDIENTM28OL1HH48GLIPIZIDE TABLET [REBEL DISTRIBUTORS CORP]1
STARCH, CORNINACTIVE INGREDIENTO8232NY3SJGLIPIZIDE TABLET [REBEL DISTRIBUTORS CORP]1
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APGLIPIZIDE TABLET [REBEL DISTRIBUTORS CORP]1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
21695-470GLIPIZIDE TABLET [REBEL DISTRIBUTORS CORP]1Legacy NDC, 5 package rows20110629_e253ec37-78bb-4168-b630-2b7e33607f9d.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
310488glipiZIDE 10 MG Oral TabletPSNe253ec37-78bb-4168-b630-2b7e33607f9d1
310490glipiZIDE 5 MG Oral TabletPSNe253ec37-78bb-4168-b630-2b7e33607f9d1
310488glipizide 10 MG Oral TabletSCDe253ec37-78bb-4168-b630-2b7e33607f9d1
310490glipizide 5 MG Oral TabletSCDe253ec37-78bb-4168-b630-2b7e33607f9d1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
21695-470-0021695047000100 in 1 BOTTLEHistorical
21695-470-302169504703030 in 1 BOTTLEHistorical
21695-470-602169504706060 in 1 BOTTLEHistorical
21695-470-7821695047078180 in 1 BOTTLEHistorical
21695-470-902169504709090 in 1 BOTTLEHistorical